Clinical Trials
3 trialsNCT06789172 2026-05-22
INVOKE
Epkin
Phase 1 Recruiting
NCT06239272 2026-05-19
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
St. Jude Children's Research Hospital
Phase 1/2 Recruiting
NCT04008238 2026-03-06
PIPER
Institut Bergonié
Phase NA Completed